6505--F-18 Pylarify / Piflufolastat - Injectable Radiopharmaceutical Ann Arbor - Nuclear Medicine Brand Name Only

Closed Special Notice Posted

Solicitation number
36C25024Q0013
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs intends to award a single-award, firm-fixed-priced contract to Progenics Pharmaceuticals, Inc., a Lantheus company, for the Nuclear Medicine Clinic at the Ann Arbor VAMC. The contract, running from 10/01/2023 until 09/30/2024, is for the provision of PYLARIFY® (piflufolastat F 18) Injection, a radioactive diagnostic agent for men with prostate cancer. The government believes Progenics Pharmaceuticals is the sole manufacturer capable of meeting this requirement.

Products and Services to be provided:

  1. PYLARIFY® (piflufolastat F 18) Injection
  2. Delivery of the product to the Nuclear Medicine Clinic at the Ann Arbor VAMC
  3. Ensuring the product meets FDA approval standards
  4. Maintaining the proprietary rights of the product
  5. Responding to inquiries and notices related to the contract.

Notice text

Description

The Department of Veterans Affairs, VHA Regional Procurement Office Central, Network Contracting Office 10, located at 3140 Governor s Place Blvd., Suite 210, Kettering, OH 45409 intends to award a single-award, firm-fixed-priced FSS contract from 10/01/2023 until 09/30/2024 to Progenics Pharmaceuticals, Inc., a Lantheus company. A determination by the Government not to compete the proposed acquisition will be based upon responses of this notice, it is solely within the discretion of the Government. Inquiries shall be emailed to LouAnn.Gilliland@va.gov. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government in future procurements. The Progenics Pharmaceuticals, Inc. s address is at 331 Treble Cove Road, North Billerica, MA, 01862, United States. This award will be for the Nuclear Medicine Clinic at the Ann Arbor VAMC, Ann Arbor, MI 48105. The acquisition is conducted under authority of the Multiple Award Schedule Program; FAR Subpart 8.405-6(b) Items Peculiar to one Manufacturer. The primary statutory authorities for the MAS program are 41 U.S.C. 152(3), Competitive Procedures, and 40 U.S.C. 501, Service for Executive Agencies. It is the Government s belief the proposed candidate is the sole manufacturer capable of meeting the requirement. The associated North America Classification Systems (NAICS) Code is 325412 and the Small Business Size Standard is 1,300 employees. It is the Government s belief the proposed candidate is the only source with the required capabilities to successfully meet the requirement for PYLARIFY® (piflufolastat F 18) Injection, which is a radioactive diagnostic agent for men with prostate cancer. This is an FDA approved, proprietary item available only through the sole manufacturer and authorized supplier of PYLARIFY. This notice satisfies the requirement at FAR 5.201(b)(1), to publicize the proposed contract action. This notice of intent is not a request for competitive proposals. No solicitation documents are available at this time. Interested parties may give written notice to LouAnn.Gilliland@va.gov by 12:00pm e.s.t. on September 11, 2023. No telephone requests will be accepted.

Files

File Type Posted
36C25024Q0013_1.docx DOCX document

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Sources Sought VISN2 DOWNSTATE GENERAL RADIOPHARMACEUTICALS Visn 2 Downstate, United States · NAICS 325412 Veterans Integrated Service Network 2 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors